7 results for “lecanemab”

By Carolyn Brandly   New drugs for the treatment of people with mild cognitive impairments and early-stage Alzheimer’s disease are grabbing headlines and attracting worldwide attention.     While the treatments may hold promise for some people, practical actions hold promise for many more people to prevent or delay dementia. Prevention…

It’s a tough question to think about, but it could yield a life-altering response depending on how you decide. If you’re having memory or word-retrieval problems, or in some other way are beginning to experience symptoms that may reflect cognitive decline, would you want to know if you are in…

Not so long ago, receiving a diagnosis of Alzheimer’s was a devastating piece of news. Usually, such a diagnosis came after specific symptoms of cognitive decline appeared. Physicians had little to offer beyond recommendations for getting your affairs in order (assuming you still had decision-making capacity when the diagnosis was…

There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…

If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…

As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…